| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +3,578 | +16% | $0.000000 | 25,395 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $23,049 | -1,226 | -4.8% | $18.80 | 24,169 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Options Exercise | $0 | +6,731 | +28% | $0.000000 | 30,900 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $43,353 | -2,306 | -7.5% | $18.80 | 28,594 | 31 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3,578 | -50% | $0.000000 | 3,579 | 31 Mar 2024 | Common Stock | 3,578 | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -6,731 | -33% | $0.000000 | 13,464 | 31 Mar 2024 | Common Stock | 6,731 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| F3 | On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |